Bristol-Myers Squibb (BMY) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

BMY Bristol-Myers Squibb

Watchlist

55.265
+0.945+1.74%

Trading Nov 4 15:38 ET

112.09BMarket Cap-15437P/E (TTM)

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Summit Therapeutics 'Unique Investment In Oncology,' Lead Drug Candidate Shows Promise Over Keytruda And Opdivo
Benzinga14:14 ET
Monday Market Mixed Before Crazy, Piovitol Week | Live Stock
Kevin Travers11:44 ET
How Is The Market Feeling About Bristol-Myers Squibb?
BenzingaNov 4 09:47 ET
Express News | Bristol-Myers Squibb Co : Leerink Partners Raises Target Price to $55 From $53
ReutersNov 4 06:10 ET
Bristol-Myers Squibb Company PFD CONV 2 Goes Ex Dividend Tomorrow
Seeking AlphaNov 4 03:25 ET
Bristol-Myers Squibb (BMY.US) announces positive phase 3 data for a potential blockbuster therapy for the treatment of schizophrenia.
Bristol-Myers Squibb (BMY.US) announced the latest topline results of the open-label Phase 3 trials EMERGENT-4 and EMERGENT-5.
Zhitong FinanceNov 2 19:35 ET

Comments

Trader’s Edge

17 hours ago

Columns BMY US is the best conviction play this week in light of election day and FOMC interest rate decision

Stocks to Watch
Abbott Laboratories (ABT US) $Abbott Laboratories (ABT.US)$
Daily Chart -[BULLISH ↗ **]ABT US is currently holding above short term ascending trendline support. As long as price is holding above 117.30 support, a further push higher towards 1st resistance at 123.80 then next resistance at 131.20 is expected. Technical indicators are advocating for a bullish scenario as well.
Altern...

Meltyy

Oct 8 07:40

🚨 1 PDUFA this week!

See FDA PDUFA update 👀 👇
📌 This Week’s PDUFA:
$ZLDPF: 🤔
‣ Dasiglucagon
‣ Congenital Hyperinsulinism
‣ PDUFA: 10/08/24
📣 Last Week’s PDUFA decisions:
$Biofrontera (BFRI.US)$ : Approved ✅
⇨ Ameluz
‣ Actinic keratosis
‣ PDUFA: 10/04/24 (sNDA)
$Bristol-Myers Squibb (BMY.US)$ : Approved ✅
⇨ Neoadjuvant Opdivo (nivolumab) + Chemo
‣ NSCLC (perioperative treatment)
‣ PDUFA: 10/08/24

Clintzilla

Sep 29 10:33

$Bristol-Myers Squibb (BMY.US)$ what a convenient dip before the 500 day on the weekly for people to accumulate before the big news.. now back to it and omg.. guess what time it is.. Big Pharm Bull Run time.. yay.. just a beautiful timed pullback.. nothing to see here.. oh and earnings on October 31st with some others cant forget that.. dividends too.. oh it just never ends

Stock_Drift

Sep 27 10:20

$Bristol-Myers Squibb (BMY.US)$

Movers and Shakers

Sep 27 07:36

Columns Today's Pre-Market Movers and Top Ratings | COST, DG, BMBL, HPQ and More

Morning Movers
Gapping up
$Bristol-Myers Squibb (BMY.US)$ Shares jumped 3.8% after the FDA approved Cobenfy as a new treatment for schizophrenia in adults, marking the first novel treatment for the mental disorder in several decades.
$Wynn Resorts (WYNN.US)$ Shares climbed 1.7% following an upgrade to overweight from equal weight by Morgan Stanley, which highlighted the company's strong fundamentals compared to its competitors...